HOME >> BIOLOGY >> NEWS
Healthy coral reefs hit hard by warmer temperatures

Coral disease outbreaks have struck the healthiest sections of Australia's Great Barrier Reef, where for the first time researchers have conclusively linked disease severity and ocean temperature. Close living quarters among coral may make it easy for infection to spread, researchers have found.

"With this study, speculation about the impacts of global warming on the spread of infectious diseases among susceptible marine species has been brought to an end," said Don Rice, director of the National Science Foundation (NSF) Chemical Oceanography Program, which funded the research through the joint NSF-National Institutes of Health Ecology of Infectious Diseases Program.

For 6 years, the international research team, led by University of North Carolina (UNC)-Chapel Hill, tracked an infection called white syndrome in 48 reefs along more than 900 miles (1,500 kilometers) of Australia's coastline.

The colorful coral colonies that attract visitors to the Great Barrier Reef live atop a limestone scaffolding built from the calcium carbonate secretions of each tiny coral, or polyp. While polyps provide the framework, coral's vivid hues come from symbiotic single-celled algae that live in the polyps. The algae supply much of the food coral need to survive.

When disease or stressful environmental conditions strike a coral colony, the polyps expel their algae. This algae loss makes the coral appear pale.

"We're left with a big question. Can corals and other marine species successfully adapt or evolve, when faced with such change?" Rice said.

Understanding the causes of disease outbreaks will help ecologists protect reef-building corals, which support commercial marine species and buffer low-lying coastal areas.

"More diseases are infecting more coral species every year, leading to the global loss of reef-building corals and the decline of other important species dependent on reefs," said lead study author Jo
'"/>

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation
7-May-2007


Page: 1 2

Related biology news :

1. Healthy reefs hit hardest by warmer temperatures
2. Healthy coastal wetlands would adapt to rising oceans
3. Second graders dig into Healthy Choices, Healthy Me!
4. Healthy coral reefs of Madagascar resisting damage from climate change
5. Healthy fruits, vegetables highlight joint medical, agricultural research meet in Texas
6. Healthy cleavage: How statins protect against Alzheimer disease
7. Healthy mix of GI tract microbes are key to preventing allergies and asthma
8. Indo-Pacific coral reefs disappearing more rapidly than expected
9. Departure to cold water corals and other hot spots
10. Investigating coral reefs to help understand past and future climate change
11. Palaus coral reefs show differential habitat recovery following the 1998 bleaching event

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Healthy coral reefs hit hard warmer temperatures

(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: